Alnylam Pharmaceuticals

Brian Newkirk

Senior Director, Head of Global Market Access and Pricing
Alnylam Pharmaceuticals

Brian Newkirk leads Alnylam Pharmaceutical’s Global Market Access and Pricing team, helping to bring the company’s highly innovative RNA-interference therapeutics to market via innovative value-based pricing models.  Prior to joining Alnylam in 2014, Brian worked from London with McKinsey and Company, helping biopharma, health system, and global public health clients address a wide range of strategic and operational challenges.  Brian began his career working on and off Capitol Hill in Washington, DC as a Congressional aide and policy analyst.  He holds an MBA from MIT, SM from the Harvard-MIT Division of Health Sciences and Technology (HST), and AB from Bowdoin College.

Brian Newkirk’s Session(s)

Copyright © 2021 Lincoln Health Network | Terms and Conditions | Privacy Policy